secwatch / observer

Shareholder Votes

Results of shareholder votes disclosed under 8-K Item 5.07.

8-K items 5.07 JSON
MUR MURPHY OIL CORP

MURPHY OIL CORP shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-05-13 meeting.

“Proposal 2 – Advisory Vote to Approve Executive Compensation 117,714,410 988,954 346,861 12,483,996”
MUR MURPHY OIL CORP

MURPHY OIL CORP shareholders approved Election of Directors at the 2026-05-13 meeting.

“Proposal 1 – Election of Directors The directors proposed by management were elected with a tabulation of votes to the nearest share as shown below.”
WNEB Western New England Bancorp, Inc.

Western New England Bancorp, Inc. shareholders approved Ratification of the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

“Proposal 3: Ratification of the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
WNEB Western New England Bancorp, Inc.

Western New England Bancorp, Inc. shareholders approved Consideration and approval of a non-binding advisory resolution on the compensation of the Company’s Named Executive Officers at the 2026-05-14 meeting.

“Proposal 2: Consideration and approval of a non-binding advisory resolution on the compensation of the Company’s Named Executive Officers . Votes Against Votes Abstain Broker Non-Votes 14,410,426 255,079 46,853 2,534,603”
WNEB Western New England Bancorp, Inc.

Western New England Bancorp, Inc. shareholders approved Election of four Directors for a three-year term expiring in 2029 at the 2026-05-14 meeting.

“Proposal 1: Election of four Directors of the Company for a three-year term expiring in 2029.”
VLTO Veralto Corp

Veralto Corp shareholders approved Advisory approval of the Company’s named executive officer compensation at the 2026-05-13 meeting.

“To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of shareholders as follows: For 198,758,419 Against 15,819,308 Abstain 292,194 Broker Non-Votes 9,322,449”
VLTO Veralto Corp

Veralto Corp shareholders approved Ratification of selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-13 meeting.

“To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The proposal was approved by a vote of shareholders as follows: For 221,833,179 Against 1,608,856 Abstain 750,335”
VLTO Veralto Corp

Veralto Corp shareholders approved Election of four Class III directors named in the Proxy Statement to a one-year term expiring at the 2027 annual meeting at the 2026-05-13 meeting.

“To elect the four Class III directors named in the Proxy Statement to a one-year term expiring at the 2027 annual meeting of shareholders and until his or her successor is elected and qualified. Each nominee for Class III director was elected by a vote of the shareholders as follows: For Against Abstain Broker Non-Votes Jennifer L. Honeycutt 213,266,768 1,407,091 196,062 9,322,449 Linda Filler 208,610,112 6,082,850 176,959 9,322,449 Heath A. Mitts 208,586,360 6,075,104 208,457 9,322,449 Thomas L. Williams 208,417,367 6,271,877 180,677 9,322,449”
CRI CARTERS INC

CARTERS INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-13 meeting.

“4. Ratification of Appointment of Independent Registered Public Accounting Firm The shareholders of the Company ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2026. The voting results were as follows: Total votes for Total votes against Total votes abstained 32,154,770 467,049 —”
CRI CARTERS INC

CARTERS INC shareholders approved Approval of the Company’s Amended and Restated Equity Incentive Plan at the 2026-05-13 meeting.

“3. Approval of the Company’s Amended and Restated Equity Incentive Plan The stockholders of the Company approved the Company’s Amended and Restated Equity Incentive Plan. The voting results were as follows: Total votes for Total votes against Total votes abstained Broker non-votes 20,978,215 7,380,358 440,677 3,931,843”
CRI CARTERS INC

CARTERS INC shareholders approved Advisory Vote on Executive Compensation for Named Executive Officers at the 2026-05-13 meeting.

“2. Advisory Vote on Executive Compensation for Named Executive Officers The stockholders of the Company approved, on an advisory basis, the 2025 compensation awarded to the Company’s named executive officers as disclosed in the Company’s proxy statement filed in connection with the Annual Meeting (the "Say-on-Pay" Vote). The voting results were as follows: Total votes for Total votes against Total votes abstained Broker non-votes 27,183,748 1,303,325 312,177 3,931,843”
CRI CARTERS INC

CARTERS INC shareholders approved Election of Directors at the 2026-05-13 meeting.

“1. Election of Directors Each of the eight director nominees were elected to a one-year term. The voting results were as follows: Name Total votes for Total votes against Total votes abstained Broker non-votes Rochester Anderson, Jr. 26,433,744 2,255,893 109,613 3,931,843 Jeffrey H. Black 26,517,459 2,176,948 104,843 3,931,843 Luis A. Borgen 26,593,692 2,100,878 104,680 3,931,843 Jevin S. Eagle 26,633,029 2,061,628 104,593 3,931,843 Mark P. Hipp 26,471,912 2,222,496 104,842 3,931,843 Stacey S. Rauch 26,418,705 2,270,913 109,632 3,931,843 Gretchen W. Schar 26,273,474 2,421,022 104,754 3,931,843 Stephanie P. Stahl 20,728,519 7,963,877 106,854 3,931,843”
HRMY Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. shareholders approved Approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers at the 2026-05-14 meeting.

“Proposal 3. The approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers pursuant to the SEC’s compensation disclosure rules.”
HRMY Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

“Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
HRMY Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. shareholders approved Election of four Class III directors at the 2026-05-14 meeting.

“Proposal 1. The election of four Class III directors listed below to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.”
BOOM DMC Global Inc.

DMC Global Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-13 meeting.

“The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 based on the following vote:”
BOOM DMC Global Inc.

DMC Global Inc. shareholders approved Approval of the Plan at the 2026-05-13 meeting.

“The stockholders approved the Plan based on the following vote:”
BOOM DMC Global Inc.

DMC Global Inc. shareholders approved Non-binding advisory vote concerning the compensation of the Company's named executive officers at the 2026-05-13 meeting.

“The non-binding advisory vote concerning the compensation of the Company's named executive officers (the “say-on-pay vote”) was approved based on the following vote:”
BOOM DMC Global Inc.

DMC Global Inc. shareholders approved Election of six directors to serve until the 2027 Annual Meeting at the 2026-05-13 meeting.

“The stockholders elected each of the six nominees to the Board to serve until the 2027 Annual Meeting based on the following vote:”
OGE OGE ENERGY CORP.

OGE ENERGY CORP. shareholders approved Shareholder proposal regarding simple majority vote at the 2026-05-14 meeting.

“Shareholder proposal regarding simple majority vote”
OGE OGE ENERGY CORP.

OGE ENERGY CORP. shareholders approved Advisory vote to approve named executive officer compensation at the 2026-05-14 meeting.

“Advisory vote to approve named executive officer compensation”
OGE OGE ENERGY CORP.

OGE ENERGY CORP. shareholders approved Ratification of the appointment of Ernst & Young LLP as OGE Energy's principal independent accountants for 2026 at the 2026-05-14 meeting.

“Ratification of the appointment of Ernst & Young LLP as OGE Energy's principal independent accountants for 2026”
OGE OGE ENERGY CORP.

OGE ENERGY CORP. shareholders approved Election of eight members of the Board of Directors at the 2026-05-14 meeting.

“At the Annual Meeting of Shareholders of OGE Energy Corp. ("OGE Energy") held on May 14, 2026, the shareholders: • Elected eight members of the Board of Directors”
BNGO Bionano Genomics, Inc.

Bionano Genomics, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-05-14 meeting.

“Proposal 3. Ratification of the Selection of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the selection of BDO USA, P.C. by the Audit Committee of the Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 3,770,715 206,541 248,739 —”
BNGO Bionano Genomics, Inc.

Bionano Genomics, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-05-14 meeting.

“Proposal 2. Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement relating to the Annual Meeting. The final voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 697,999 216,553 76,839 3,234,604”
BNGO Bionano Genomics, Inc.

Bionano Genomics, Inc. shareholders approved Election of Directors at the 2026-05-14 meeting.

“Proposal 1. Election of Directors. The Company’s stockholders elected the two persons listed below as Class II Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. The final voting results were as follows: Name Votes For Votes Withheld Broker Non-Votes Albert Luderer, Ph.D. 847,601 143,790 3,234,604 Kristiina Vuori, M.D., Ph.D. 867,474 123,917 3,234,604”
FLGT Fulgent Genetics, Inc.

Fulgent Genetics, Inc. shareholders approved Approval of the Company's 2026 Equity Incentive Plan. at the 2026-05-14 meeting.

“Proposal 4 Approval of the Company's 2026 Equity Incentive Plan. Votes For Votes Against Votes Abstained Broker Non-Vote 18,693,758 3,513,983 48,202 2,323,053”
FLGT Fulgent Genetics, Inc.

Fulgent Genetics, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers. at the 2026-05-14 meeting.

“Proposal 3 Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Vote 19,800,226 2,410,239 45,478 2,323,053”
FLGT Fulgent Genetics, Inc.

Fulgent Genetics, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-14 meeting.

“Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained Broker Non-Vote 24,470,414 87,192 21,390 —”
FLGT Fulgent Genetics, Inc.

Fulgent Genetics, Inc. shareholders approved Election of the following nominees as directors of the Company, each to serve until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. at the 2026-05-14 meeting.

“Proposal 1 Election of the following nominees as directors of the Company, each to serve until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. Votes For Votes Withheld Broker Non-Vote Ming Hsieh 21,979,668 276,275 2,323,053 Linda Dong 16,836,781 5,419,162 2,323,053 Michael Nohaile, Ph.D. 17,258,629 4,997,314 2,323,053 Regina Groves 16,240,666 6,015,277 2,323,053”
AIG AMERICAN INTERNATIONAL GROUP, INC.

AMERICAN INTERNATIONAL GROUP, INC. shareholders approved Ratify Appointment of PricewaterhouseCoopers LLP to Serve as AIG’s Independent Auditor for 2026 at the 2026-05-13 meeting.

“Proposal 3 – Ratify Appointment of PricewaterhouseCoopers LLP to Serve as AIG’s Independent Auditor for 2026: The voting results were as follows: For Against Abstain Broker Non-Votes 463,063,134 29,719,774 182,720 —”
AIG AMERICAN INTERNATIONAL GROUP, INC.

AMERICAN INTERNATIONAL GROUP, INC. shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-05-13 meeting.

“Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation: The voting results were as follows: For Against Abstain Broker Non-Votes 359,800,583 104,658,356 919,613 27,587,076”
AIG AMERICAN INTERNATIONAL GROUP, INC.

AMERICAN INTERNATIONAL GROUP, INC. shareholders approved Election of Directors at the 2026-05-13 meeting.

“Proposal 1 – Election of Directors: The following individuals were elected to serve as members of AIG’s Board of Directors until the 2027 Annual Meeting or until the election and qualification of their successors. The voting results for each of the nominees were as follows: For Against Abstain Broker Non-Votes James Cole, Jr. 461,745,104 3,346,458 286,990 27,587,076 John (Chris) Inglis 464,807,207 288,027 283,318 27,587,076 Courtney Leimkuhler 464,795,836 312,876 269,840 27,587,076 Linda A. Mills 413,428,551 51,680,818 269,183 27,587,076 Diana M. Murphy 423,706,844 41,123,373 548,335 27,587,076 Juan R. Perez 427,447,276 37,657,485 273,791 27,587,076 Peter R. Porrino 462,018,628 3,084,547 275,377 27,587,076 John G. Rice 461,756,522 3,192,529 429,501 27,587,076 Vanessa A. Wittman 464,601,110 509,736 267,706 27,587,076 Peter Zaffino 453,589,684 11,532,819 256,049 27,587,076”
SRE SEMPRA

SEMPRA shareholders rejected Shareholder Proposal Requesting an Independent Board Chairman at the 2026-05-12 meeting.

“did not approve a shareholder proposal requesting an independent board chairman”
SRE SEMPRA

SEMPRA shareholders approved Advisory Approval of the Company’s Executive Compensation at the 2026-05-12 meeting.

“approved, on an advisory basis, the Company’s executive compensation as reported in the Company’s proxy statement for the Annual Meeting”
SRE SEMPRA

SEMPRA shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-12 meeting.

“ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2026”
SRE SEMPRA

SEMPRA shareholders approved Election of Directors at the 2026-05-12 meeting.

“elected for the ensuing year all eleven of the director nominees up for election and listed below”
CWK Cushman & Wakefield Ltd.

Cushman & Wakefield Ltd. shareholders approved Approve the 2026 Omnibus Share and Cash Incentive Plan at the 2026-05-14 meeting.

“4. To approve the 2026 Plan. 191,432,616 17,159,619 72,337 11,469,542”
CWK Cushman & Wakefield Ltd.

Cushman & Wakefield Ltd. shareholders approved To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement at the 2026-05-14 meeting.

“3. To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (“Say on Pay”). 203,900,649 4,706,771 57,152 11,469,542”
CWK Cushman & Wakefield Ltd.

Cushman & Wakefield Ltd. shareholders approved To appoint KPMG LLP as independent auditor for the year ending December 31, 2026 and to authorize the Audit Committee of its Board to set the independent auditor's remuneration at the 2026-05-14 meeting.

“2. To appoint KPMG LLP as independent auditor for the year ending December 31, 2026 and to authorize the Audit Committee of its Board to set the independent auditor’s remuneration. 218,134,007 1,923,817 76,290 —”
CWK Cushman & Wakefield Ltd.

Cushman & Wakefield Ltd. shareholders approved Election of three nominees to the Board for a one-year term expiring at the 2027 annual general meeting at the 2026-05-14 meeting.

“1. To elect the three nominees named in the Proxy Statement to the Board to a one-year term expiring at the 2027 annual general meeting: Jodie McLean 202,181,285 6,450,424 32,863 11,469,542 Timothy Wennes 208,444,766 186,493 33,313 11,469,542 Billie Williamson 208,316,314 315,390 32,868 11,469,542”
CMRC Commerce.com, Inc.

Commerce.com, Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-05-14 meeting.

“Proposal 3 – Advisory vote on the compensation of the Company’s named executive officers: Votes For Votes Against Votes Abstaining Broker Non-Votes 41,815,910 2,042,635 844,410 15,233,039”
CMRC Commerce.com, Inc.

Commerce.com, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

“Proposal 2 – Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Votes Abstaining Broker Non-Votes 58,871,277 1,022,291 42,426 –”
CMRC Commerce.com, Inc.

Commerce.com, Inc. shareholders approved Election of Class III Directors to serve a term of three years at the 2026-05-14 meeting.

“Proposal 1 – Election of Class III Directors to serve a term of three years: Votes For Votes Withheld Broker Non-Votes Donald E. Clarke 28,873,697 15,829,258 15,233,039 Ellen Siminoff 30,568,355 14,134,600 15,233,039”
ECG Everus Construction Group, Inc.

Everus Construction Group, Inc. shareholders approved Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for 2026 at the 2026-05-12 meeting.

“3. Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for 2026. Shares For Shares Against Abstentions 45,964,113 115,052 126,829 The proposal was approved, having received the affirmative vote of a majority of the common stock present in person or represented by proxy at the Annual Meeting and entitled to vote on the proposal.”
ECG Everus Construction Group, Inc.

Everus Construction Group, Inc. shareholders approved Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers at the 2026-05-12 meeting.

“2. Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers. Shares For Shares Against Abstentions Broker Non-Votes 38,751,045 1,389,325 164,861 5,900,763 The proposal was approved, on a non-binding advisory basis, having received the affirmative vote of a majority of the common stock present in person or represented by proxy at the Annual Meeting and entitled to vote on the proposal .”
ECG Everus Construction Group, Inc.

Everus Construction Group, Inc. shareholders approved Election of Eight Directors for One-Year Terms at the 2026-05-12 meeting.

“1. Proposal to Elect Eight Directors for One-Year Terms. Nominee Shares For Shares Against Abstentions Broker Non-Votes Michael S. Della Rocca 38,996,458 1,247,191 61,582 5,900,763 Helena M. Hernandez 39,679,867 561,437 63,927 5,900,763 Dale S. Rosenthal 38,877,046 1,333,841 94,344 5,900,763 Edward A. Ryan 35,600,613 4,621,907 82,711 5,900,763 David M. Sparby 39,860,987 350,160 94,084 5,900,763 Jeffrey S. Thiede 40,058,907 182,690 63,634 5,900,763 Clark A. Wood 38,933,757 1,301,974 69,500 5,900,763 Betty R. Wynn 39,818,888 358,215 128,128 5,900,763 All of the Company’s nominees were elected, having received more votes cast “for” their election than “against” their election.”
DRS Leonardo DRS, Inc.

Leonardo DRS, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

“Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026 255,915,526 57,972 32,759 0”
DRS Leonardo DRS, Inc.

Leonardo DRS, Inc. shareholders approved Advisory Resolution Regarding Compensation of the Company’s NEOs at the 2026-05-14 meeting.

“Shares Voted For Shares Voted Against Abstentions Broker Non-Votes Advisory Resolution Regarding Compensation of the Company’s NEOs 249,961,000 246,614 87,846 5,710,797”
DRS Leonardo DRS, Inc.

Leonardo DRS, Inc. shareholders approved Election of Directors at the 2026-05-14 meeting.

“Election of Directors Shares Voted For Shares Voted Against Withheld Broker Non-Votes Frances F. Townsend 249,645,446 N/A 650,014 5,710,797 Gail S. Baker 249,983,388 N/A 312,072 5,710,797 John A. Baylouny 250,199,261 N/A 96,199 5,710,797 Dr. Louis R. Brothers 250,007,405 N/A 288,055 5,710,797 General George W. Casey, Jr. 250,005,085 N/A 290,375 5,710,797 Mary E. Gallagher 249,969,944 N/A 325,516 5,710,797 Reuben Jeffery III 250,193,834 N/A 101,626 5,710,797 Kenneth J. Krieg 247,306,328 N/A 2,989,132 5,710,797 Eric C. Salzman 249,916,267 N/A 379,193 5,710,797”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.